iThera Medical GmbH has closed a Series D financing round with a volume of Euro 13 million.

The funding round is the next major step to translate iThera-MSOT technology from a tool in research to a diagnostic asset in a clinical setting, where it will be a game-changer for millions of patients worldwide.

Read more.